Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Somatostatinoma 1Pheochromocytoma 1Neurofibrosarcoma 1Neurofibromatosis 1 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Melanoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Kidney Neoplasms 1Insulinoma 1Glucagonoma 1Gastrinoma 1Fibrosis 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Islet Cell 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Trastuzumab 2Everolimus 2veliparib 1vatalanib 1tipifarnib 1pentetreotide 1fluorodopa F 18 1cixutumumab 1Temozolomide 1Salts 1Oxaliplatin 1Octreotide 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1High-Energy Shock Waves 1Floxuridine 1Capecitabine 1Acetates 190Y-octreotide, DOTA-Tyr(3)- 168Ga-NOTA-exendin-4 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Insulinoma × High-Energy Shock Waves × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡